ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage.

July 12, 1991

Cohen Directs UK’s Markey Cancer Center; Matrisian Named Chairman, DOD Panel.

September 8, 2000

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

May 13, 1994

Foreeman, Brinker, Jako Appointed To Cancer Panel

April 19, 1991

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993